The association of funding source on effect size in randomized controlled trials: 2013–2015 – a cross-sectional survey and meta-analysis

被引:0
作者
Alberto Falk Delgado
Anna Falk Delgado
机构
[1] Uppsala University Hospital,Department of Surgical Sciences
[2] Karolinska Institutet,Department of Clinical Neuroscience
[3] Uppsala University Hospital,Neuroradiology
[4] Akademiska sjukhuset,undefined
[5] Karolinska University Hospital,undefined
来源
Trials | / 18卷
关键词
For-profit; Surrogate; Funding; Endpoint; Odds ratio;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 130 条
[1]  
Lundh A(2012)Industry sponsorship and research outcome Cochrane Database Syst Rev 12 MR000033-65
[2]  
Sismondo S(2003)Scope and impact of financial conflicts of interest in biomedical research: a systematic review JAMA 289 454-4
[3]  
Lexchin J(2006)Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000–2005 JAMA 295 2270-8
[4]  
Busuioc OA(2000)The uncertainty principle and industry-sponsored research Lancet 356 635-8
[5]  
Bero L(2003)Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290 921-6
[6]  
Bekelman JE(2002)Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ 325 249-43
[7]  
Li Y(2014)Industry collaboration and randomized clinical trial design and outcomes JAMA Intern Med 174 1695-30
[8]  
Gross CP(2013)Authors’ self-declared financial conflicts of interest do not impact the results of major cardiovascular trials J Am Coll Cardiol 61 1137-70
[9]  
Ridker PM(2007)Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data BMC Med Res Methodol 7 5-18
[10]  
Torres J(2011)Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study Trials 12 58-5